Personalis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.About PSNL
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives.
CEOChristopher M. Hall
CEOChristopher M. Hall
Employees229
Employees229
HeadquartersFremont, California
HeadquartersFremont, California
Founded2011
Founded2011
Employees229
Employees229
PSNL Key Statistics
Market cap878.28M
Market cap878.28M
Price-Earnings ratio-11.29
Price-Earnings ratio-11.29
Dividend yield—
Dividend yield—
Average volume1.42M
Average volume1.42M
High today$10.47
High today$10.47
Low today$9.42
Low today$9.42
Open price$9.68
Open price$9.68
Volume3.11M
Volume3.11M
52 Week high$11.40
52 Week high$11.40
52 Week low$2.83
52 Week low$2.83
Stock Snapshot
As of today, Personalis(PSNL) shares are valued at $9.88. The company's market cap stands at 878.28M, with a P/E ratio of -11.29.
During the trading session on 2026-01-17, Personalis(PSNL) shares reached a daily high of $10.47 and a low of $9.42. At a current price of $9.88, the stock is +4.9% higher than the low and still -5.6% under the high.
Trading volume for Personalis(PSNL) stock has reached 3.11M, versus its average volume of 1.42M.
Over the past 52 weeks, Personalis(PSNL) stock has traded between a high of $11.40 and a low of $2.83.
Over the past 52 weeks, Personalis(PSNL) stock has traded between a high of $11.40 and a low of $2.83.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own PSNL. This list is generated using Robinhood data, and it’s not a recommendation.